Literature DB >> 2731994

Comparison of the anti-anaphylactic effects of milrinone, sulmazole and theophylline in the rat.

M J Post1, J D te Biesebeek, J Wemer, H H van Rooij, A J Porsius.   

Abstract

Milrinone and sulmazole, two recently developed cardiotonic drugs, inhibit specific fractions of the phosphodiesterase (PDE) isozyme system, while theophylline inhibits the PDE complex aspecifically. Since these drugs were shown to have anti-allergic effects in isolated lungs, we wanted to study milrinone and sulmazole in comparison with theophylline in an in vivo model of anaphylaxis. For this purpose, actively sensitized rats were intravenously challenged with antigen, while tracheal pressure, oesophageal pressure, blood pressure and airflow were continuously monitored. Antigen challenge induced a transient bronchoconstriction and a persistent fall in blood pressure until death occurred. Anaphylactic shock was consistently followed by metabolic acidosis. Milrinone, 3 mg/kg, and theophylline, 40 mg/kg (but not 10 mg/kg), reduced anaphylactic bronchoconstriction. Sulmazole, 40 mg/kg, almost abolished bronchoconstriction. Although milrinone, sulmazole and theophylline, 40 mg/kg, caused a fall in blood pressure prior to antigen challenge, total fall in blood pressure (drug-induced and antigen-induced) was not affected by these drugs. Surprisingly, sulmazole reduced mortality significantly. This phenomenon is probably related to the less severe metabolic acidosis in the presence of sulmazole.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2731994     DOI: 10.1159/000234915

Source DB:  PubMed          Journal:  Int Arch Allergy Appl Immunol        ISSN: 0020-5915


  3 in total

1.  Use of enoximone in management of anaphylaxis complicated by labetalol use.

Authors:  Sophie Hayhoe; Vilas Navapurkar; Andrew Conway Morris
Journal:  BMJ Case Rep       Date:  2015-10-26

2.  Lactic acid suppresses IgE-mediated mast cell function in vitro and in vivo.

Authors:  Daniel Abebayehu; Andrew J Spence; Heather Caslin; Marcela Taruselli; Tamara T Haque; Kasalina N Kiwanuka; Elizabeth Motunrayo Kolawole; Alena P Chumanevich; Scott A Sell; Carole A Oskeritzian; John Ryan; Sydney Ann Kee
Journal:  Cell Immunol       Date:  2019-04-12       Impact factor: 4.868

3.  Comparative Pro-cognitive and Neurochemical Profiles of Glycine Modulatory Site Agonists and Glycine Reuptake Inhibitors in the Rat: Potential Relevance to Cognitive Dysfunction and Its Management.

Authors:  Kevin C F Fone; David J G Watson; Rodolphe I Billiras; Dorothee I Sicard; Anne Dekeyne; Jean-Michel Rivet; Alain Gobert; Mark J Millan
Journal:  Mol Neurobiol       Date:  2020-01-20       Impact factor: 5.590

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.